<DOC>
	<DOCNO>NCT00886678</DOCNO>
	<brief_summary>Patients inoperable Non-Small-Cell Lung Cancer receive thoracic radiation therapy 66 Gy 33 fraction , concurrent 2 cycle chemotherapy pemetrexed ( 500 mg/m2 , d1 , repeat every 3 week ) carboplatin ( AUC=5 , d1 , repeat every 3 week ) .</brief_summary>
	<brief_title>A Study Pemetrexed Plus Carboplatin Combined With Radiation Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer ( LA-NSCLC ) ( RT0801 )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Histologically proven nonsmall cell lung cancer ( nonsquamous cell carcinoma ) Presence measurable disease RECIST Inoperable stage IIIA IIIB ECOG performance status 01 No prior chemotherapy , radiation therapy chest , immunotherapy , biologic therapy Patients must sign informed consent indicate aware investigational nature study keep policy hospital . Carcinoid tumor , small cell carcinoma lung Patients distant metastasis History another malignancy within last five year except cure basal cell carcinoma skin cure carcinoma insitu uterine cervix Any morbidity situation contraindication chemotherapy ( e.g . active infection , myocardial infarction precede 6 month , symptomatic heart disease include unstable angina , congestive heart failure uncontrolled arrhythmia , immunosuppressive treatment ) Pregnant lactate woman , woman take test pregnancy ( within 14 day first administration ) pregnant woman Women men childbearing potential willing employ adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Non-Small Cell Lung Cancer</keyword>
	<keyword>pemetrexed</keyword>
	<keyword>radiation</keyword>
</DOC>